Organovo Holdings Inc ONVO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:56 AM EST
13.30quote price arrow up+0.55 (+4.31%)
Volume
878
Close
12.75quote price arrow down-0.03 (-0.23%)
Volume
468,317
52 week range
3.87 - 23.92

...

Loading . . .

KEY STATS

  • Open13.48
  • Day High13.76
  • Day Low12.30
  • Prev Close12.75
  • 52 Week High23.92
  • 52 Week High Date02/11/21
  • 52 Week Low3.87
  • 52 Week Low Date03/17/20
  • Market Cap90.78M
  • Shares Out7.12M
  • 10 Day Average Volume0.70M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • 1 Year % Change104.98

RATIOS/PROFITABILITY

  • EPS (TTM)-2.57
  • P/E (TTM)-4.96
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-14.359M
  • ROE (MRQ)-68.21%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)95.64%
  • Net Margin (MRQ)-5,977.18%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date06/01/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest ONVO News From Our Partners

QUOTE FINDER

Profile

MORE
Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption...
Keith Murphy
Chairman
Chris Heberlig
President
Thomas Jurgensen J.D.
General Counsel
Address
440 Stevens Avenue, Suite 200
Solana Beach, CA
92075
United States